Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
A tea exosome-integrated self‑oxygenating cascade chitosan/oxidized alginate hydrogel for remodeling the hyperglycemic and hypoxic microenvironment in diabetic wound healing
Carbohydrate polymers, 2026;389:125628
Semaglutide Modulates Visceral Adipose Tissue Lipid Metabolism in Type 2 Diabetic Mice: A Lipidomics Study
Frontiers in bioscience (Landmark edition);31(6):49873
Sirtuin 1 deficiency mediates chronic kidney disease-induced inflammaging cardiovascular calcification
Molecular biomedicine, 2026;7(1)
Role of GLP-1 receptor agonists in the prevention and treatment of obesity-related cancer
Internal and emergency medicine, 2026
Preventative semaglutide and tirzepatide treatment does not alter disease progression in the 5xFAD mouse model of Alzheimer’s disease
Cell reports. Medicine, 2026;:102906
A Sequential Dual GLP-1R/GIPR Agonist-To-Antagonist Molecule Achieves Superior Weight Loss in Obese Mice
Diabetes, obesity & metabolism, 2026
Overcoming Gastric Barriers for Oral Peptide Delivery: QbD-Based Development of Sodium Caprate-Enabled Tirzepatide Tablets
Pharmaceutics, 2026;18(7)
Quantitative MRI Pharmacokinetic Modeling and MALDI Mass Spectrometry Imaging Biodistribution of a pH Mapping MRI Contrast Agent
Theranostics, 2026;16(14):7937-7957
Lead-guided prodrug development of small molecules as GLP-1R agonists
Bioorganic chemistry, 2026;180:110210
PCSK5 promotes angiogenesis and cardiac repair after myocardial infarction
Nature communications, 2026;17(1)
Females Are Completely Resistant to Semaglutide-Induced Muscle Loss in ob/ob Mice
Diabetes, 2026
Effects of Retatrutide on Learning and Memory in Streptozotocin-Induced Male Diabetic Rats
Behavioural brain research, 2026;:116343
Discovery of DDO-4279 as a PP5 degrader for the treatment of obesity
RSC medicinal chemistry, 2026
Differential Anti-Inflammatory Effects of Semaglutide and Tirzepatide in Experimental Diabetes Mellitus
Current issues in molecular biology, 2026;48(7)
A trispecific GLP-1/anti-GIPR/FGF21 peptibody exhibits favorable metabolic effects in a diet-induced obesity model
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026;201:119717
GLP-1 Receptor Agonists and the Ocular Surface: A Narrative Review of Restoration, Remodeling, and Clinical Implications
Ophthalmology and therapy, 2026
Chronic semaglutide alters ingestive behavior without impairing taste function in mice
Molecular metabolism, 2026;:102410
From dual to quintuple agonism for next-generation pharmacology to treat obesity and type 2 diabetes: synergistic incretin and nuclear receptor signaling
Cardiovascular diabetology. Endocrinology reports, 2026;12(1)
Hydrophobic ion pairing formed semaglutide designed for oral self-microemulsifying delivery in diabetes treatment
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2026;:115167
Tirzepatide, a dual GIP/GLP-1 receptor agonist, attenuates endothelial dysfunction and angiotensin II-induced abdominal aortic aneurysm in ApoE-/- mice
Pharmacological research, 2026;:108321